Allergan inc (AGN)
CashFlow / TTM
Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Cash flows from operating activities:
Net earnings

1,528,800

1,302,000

1,289,400

1,232,200

988,700

1,001,600

951,400

886,600

1,102,500

1,057,000

1,057,400

1,009,600

938,100

921,500

1,800

-5,300

4,900

-35,400

812,500

747,800

623,800

0

0

0

Non-cash items included in net earnings:
Depreciation and amortization

248,100

244,500

241,200

242,100

254,600

260,300

264,100

267,000

256,600

255,400

254,400

252,700

253,400

252,600

250,400

254,200

257,100

259,700

262,500

259,400

262,100

0

0

0

Amortization of original issue discount and debt issuance costs

2,800

2,800

2,800

2,800

2,600

2,400

2,100

1,900

1,900

1,900

1,900

2,700

9,700

16,600

23,300

29,000

28,400

27,800

27,400

27,100

27,500

0

0

0

Amortization of net realized gain on interest rate swaps

-15,000

-14,800

-14,600

-14,500

-14,400

-14,300

-14,200

-11,000

-7,700

-4,500

-1,300

-1,300

-1,300

-1,300

-1,300

-1,300

-1,300

-1,300

-1,300

-1,300

-1,300

0

0

0

Deferred income tax benefit

-79,800

-71,500

-87,000

-99,600

-192,200

-181,800

-177,300

-174,400

-88,300

-58,700

-37,000

-44,900

-68,900

-149,300

-287,400

-263,600

-249,100

-207,200

-74,900

-84,600

-112,800

0

0

0

Acquired in-process research and development technology

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal and impairment of assets

-29,800

-10,600

-5,300

-5,500

-5,800

-4,600

-6,900

-6,100

-5,700

-7,100

-2,100

-1,600

0

-27,900

-16,500

-16,800

-17,900

4,900

-200

-300

-3,800

0

0

0

Loss on extinguishment of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,300

0

0

0

Unrealized (gain) loss on derivative instruments

37,200

25,100

-16,600

4,900

10,400

4,200

4,700

-1,500

-15,300

-16,100

7,800

5,500

11,100

-2,600

-4,200

-15,200

-7,600

-23,800

-7,300

-10,100

-13,600

0

0

0

Expense of share-based compensation plans

159,700

136,900

123,700

120,100

114,400

114,000

113,100

112,100

109,100

101,700

97,200

91,500

86,300

84,800

80,500

76,500

73,900

72,000

70,800

71,900

151,900

0

0

0

Loss on sale of discontinued operations

0

-3,300

-62,000

-62,000

-408,200

-404,900

-346,200

-346,200

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets and related costs

-

-

-

-

-

-

-

-

-

-

-

-

20,400

0

0

0

-

-

-

-

-

-

-

-

(Income) expense from changes in fair value of contingent consideration

-15,100

50,400

70,800

64,600

70,700

-5,600

-4,700

10,600

5,400

25,400

23,000

12,500

11,900

0

0

0

-

-

-

-

-

-

-

-

Restructuring charges

246,400

208,900

24,000

25,500

5,500

5,900

9,100

10,000

5,700

4,700

800

0

4,600

4,100

4,300

4,300

300

4,400

8,500

9,400

50,900

0

0

0

Intangible asset impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Loss on investments

-3,100

0

0

0

-3,700

-3,700

-3,700

-3,700

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Trade receivables

115,700

110,400

105,100

90,300

139,600

56,600

75,100

63,000

34,300

175,000

178,000

215,500

105,600

164,500

199,100

74,000

71,400

20,300

-62,800

20,100

17,700

0

0

0

Inventories

43,800

29,200

18,100

39,200

26,900

17,700

16,900

2,700

7,300

16,800

28,800

21,800

24,000

24,100

2,400

15,400

5,600

-117,600

-23,800

-67,000

-67,700

0

0

0

Other current assets

23,300

33,500

25,300

1,800

800

-26,600

-11,700

16,500

16,000

26,100

19,600

20,100

33,100

16,000

-9,400

20,300

-7,300

-26,500

31,500

-19,800

-4,900

0

0

0

Other non-current assets

29,700

20,800

23,700

16,900

15,500

10,600

-38,900

-46,700

-44,100

-46,500

10,300

13,900

13,400

42,500

27,600

26,700

18,600

30,000

18,100

20,400

20,300

0

0

0

Accounts payable

1,900

9,700

59,800

89,300

37,400

41,700

22,300

-300

32,700

26,400

13,700

6,800

-19,300

-100

1,800

-47,100

8,600

-48,500

-6,700

47,500

22,500

0

0

0

Accrued expenses

115,900

155,100

164,600

129,700

110,200

17,200

21,100

25,400

73,100

131,200

69,500

74,200

39,100

22,900

35,700

40,000

34,400

73,400

73,100

39,100

16,200

0

0

0

Income taxes

-124,000

-89,000

-35,400

18,000

64,900

34,400

4,200

4,600

52,400

56,500

82,200

7,500

-19,800

-34,000

-86,200

-11,900

-17,600

22,900

32,900

19,600

-1,600

0

0

0

Other liabilities

25,500

-29,700

-29,000

-4,400

17,100

31,200

38,500

33,800

26,700

28,900

13,000

10,900

13,600

11,200

30,500

18,100

-5,100

4,600

20,500

34,100

41,400

0

0

0

Net cash provided by operating activities

1,927,800

1,748,900

1,733,400

1,741,600

1,695,400

1,680,000

1,562,700

1,510,600

1,599,900

1,480,400

1,338,900

1,152,600

1,081,900

344,500

333,900

428,800

463,900

1,142,700

1,175,400

1,170,100

1,113,300

0

0

0

Cash flows from investing activities:
Purchases of short-term investments

1,269,800

1,650,900

1,950,700

1,639,900

1,025,600

805,100

545,300

695,300

865,200

884,500

751,000

641,100

571,100

716,000

1,148,900

974,000

824,100

0

0

0

-

-

-

-

Purchases of equity investments

20,300

10,000

10,000

10,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisitions, net of cash acquired

67,500

67,500

0

20,700

892,100

1,238,200

1,238,200

1,217,500

349,200

5,600

97,500

104,500

101,400

98,900

13,100

6,100

69,800

0

0

0

-

-

-

-

Additions to property, plant and equipment

243,900

259,900

219,400

194,600

171,900

142,600

148,400

143,900

143,300

141,300

129,600

124,600

118,600

127,900

119,100

107,400

102,800

96,000

98,400

96,800

95,800

0

0

0

Additions to capitalized software

19,000

15,800

14,800

12,700

11,800

15,000

15,800

14,900

13,900

10,800

8,800

9,600

11,200

11,000

12,700

13,700

13,300

14,700

15,900

20,600

26,600

0

0

0

Additions to intangible assets

15,000

15,000

10,000

0

300

300

900

4,400

4,100

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of short-term investments

1,815,900

1,899,000

1,608,000

888,200

683,200

560,400

665,400

995,200

784,600

671,100

746,000

541,000

1,140,300

1,148,900

849,100

724,300

75,000

0

0

0

-

-

-

-

Proceeds from sale of business

1,800

44,500

44,500

44,500

42,700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contractual purchase price adjustment to prior acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,700

0

0

0

-

-

-

-

Proceeds from sale of property, plant and equipment

500

400

600

500

500

900

1,300

1,600

1,800

1,400

1,000

1,300

1,200

1,500

1,200

600

400

0

0

0

-

-

-

-

Net cash provided by (used in) investing activities

182,700

-75,200

-551,800

-944,700

-1,375,300

-1,639,900

-1,281,900

-1,079,200

-589,300

-373,300

-242,700

-335,900

340,800

175,300

-483,500

-417,200

-977,200

-703,000

-167,600

-159,100

-98,700

0

0

0

Cash flows from financing activities:
Repayments of convertible borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

98,300

0

0

0

Dividends to stockholders

59,600

59,500

59,500

59,400

59,400

59,600

59,700

60,100

60,400

60,700

60,900

61,000

61,100

61,000

60,900

60,800

60,600

60,500

60,600

60,500

60,600

0

0

0

Payments to acquire treasury stock

839,200

836,500

835,600

400,300

650,700

835,000

1,009,100

1,340,500

909,000

811,000

711,700

515,700

461,700

461,100

449,300

389,300

286,000

0

0

0

-

-

-

-

Payments of contingent consideration

10,200

60,300

60,300

58,700

61,200

11,100

11,100

10,100

5,100

5,100

5,100

5,200

3,000

3,000

3,000

2,900

0

0

0

0

-

-

-

-

Net borrowings (repayments) of notes payable

16,500

18,600

9,300

3,800

6,800

-3,600

9,200

-30,500

-35,100

-38,100

-33,700

26,300

30,700

35,300

37,900

18,300

6,600

-1,200

-4,100

11,900

12,100

0

0

0

Debt issuance costs

0

0

0

1,100

4,800

4,800

4,800

3,700

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of senior notes, net of discount

0

0

0

0

598,500

598,500

598,500

598,500

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Sale of stock to employees

521,000

407,500

374,500

284,700

179,300

252,600

259,900

271,500

246,400

212,200

212,900

270,700

264,000

349,100

355,400

278,400

234,000

121,500

109,900

94,500

63,500

0

0

0

Excess tax benefits from share-based compensation

167,500

118,200

103,800

65,900

37,700

54,800

56,500

61,600

45,700

41,400

41,000

48,000

37,700

43,200

43,800

31,700

27,100

9,100

8,300

7,200

7,300

0

0

0

Net cash (used in) provided by financing activities

-204,000

-430,000

-485,800

-183,100

28,200

-8,200

-160,600

-513,300

-717,500

-661,300

-557,500

-1,045,800

-1,002,300

-906,500

-243,100

517,300

563,000

473,100

-156,800

-112,000

-181,500

0

0

0

Effect of exchange rate changes on cash and equivalents

-41,200

-19,200

10,100

2,700

-4,000

-600

-4,900

-11,000

2,600

-2,800

-26,500

-10,000

-5,500

-4,600

29,600

12,200

-5,600

-8,100

-19,500

2,400

3,600

0

0

0

Net increase in cash and equivalents

1,865,300

1,224,500

705,900

616,500

344,300

31,300

115,300

-92,900

295,700

443,000

512,200

-239,100

414,900

-391,300

-363,100

541,100

44,100

904,700

831,500

901,400

836,700

0

0

0

Supplemental disclosure of cash flow information
Cash paid for:
Interest, net of amount capitalized

83,400

87,900

89,000

88,900

83,300

79,300

69,000

63,200

64,200

57,700

61,600

65,500

64,500

69,400

58,100

58,700

48,000

47,500

47,000

47,200

53,700

0

0

0

Income taxes, net of refunds

487,800

585,500

555,000

507,500

455,300

436,500

432,300

417,300

407,000

353,000

327,800

373,100

399,300

449,300

486,700

399,400

410,800

365,700

326,200

337,900

332,600

0

0

0